Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07467460) titled 'Precision Medicine and Neurodegenerative Diseases: Advanced Systems for the Diagnosis and Treatment of Parkinson's Disease and Alzheimer's Disease' on March 9.

Study Type: Observational [Patient Registry]

Primary Sponsor: Neuromed IRCCS

Condition: PARKINSON DISEASE (Disorder) Alzheimer s Disease Diabete Type 2

Recruitment Status: Recruiting

Date of First Enrollment: February 17, 2026

Target Sample Size: 500

Countries of Recruitment: Italy

To know more, visit https://clinicaltrials.gov/study/NCT07467460

Disclaimer: Curated by HT Syndication....